The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLloyds Regulatory News (LLOY)

Share Price Information for Lloyds (LLOY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 54.80
Bid: 54.70
Ask: 54.74
Change: -0.98 (-1.76%)
Spread: 0.04 (0.073%)
Open: 55.22
High: 55.22
Low: 54.22
Prev. Close: 55.78
LLOY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of Final Terms

12 Jan 2022 17:54

RNS Number : 2733Y
Lloyds Banking Group PLC
12 January 2022
 

RNS announcement

 

Publication of Final Terms

 

The following Final Terms are available for viewing:

 

Final Terms dated 10 January 2022, for Lloyds Banking Group plc GBP 500,000,000 Fixed Rate Reset Callable Notes due 2028 (the "Notes") issued pursuant to the base prospectus dated 17 June 2021 as supplemented by the supplemental prospectuses dated 29 July 2021 and 28 October 2021 (together, the "Prospectus") in connection with the £25,000,000,000 Euro Medium Term Note Programme established by Lloyds Banking Group plc.

 

The Final Terms for the Notes contain the final terms of the Notes. The Final Terms of the Notes must be read in conjunction with the Prospectus, which constitutes a base prospectus for the purposes of Regulation (EU) 2017/1129 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018, as amended (the "UK Prospectus Regulation").

 

To view the full documents, please paste the following URL into the address bar of your browser.

http://www.rns-pdf.londonstockexchange.com/rns/2733Y_1-2022-1-12.pdf

 

A copy of the Final Terms and the Prospectus have been submitted to the National Storage Mechanism and will shortly be available for inspection at: www.Hemscott.com/nsm.do.

 

For further information, please contact:

 

Investor Relations:

 

Douglas Radcliffe

Group Investor Relations Director 

Tel: +44 20 7356 1571

Email: douglas.radcliffe@finance.lloydsbanking.com

 

Corporate Affairs:

 

Matt Smith

Head of Corporate Media

Tel: +44 20 7356 3522

Email: matt.smith@lloydsbanking.com

 

Lloyds Banking Group plc

Registered Office

The Mound

Edinburgh

EH1 1YZ

 

 

Disclaimer - Intended Addressees

 

Please note that the information contained in the Final Terms and the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Final Terms or the Prospectus is not addressed. Prior to relying on the information contained in the Final Terms or the Prospectus, you must ascertain from the Final Terms and/or the Prospectus whether or not you are part of the intended addressees of the information contained therein.

Your right to access this service is conditional upon complying with the above requirement.

UK MIFIR professionals/ECPs-only/ No UK PRIIPs KID- Manufacturer target market (UK MIFIR product governance) is eligible counterparties and professional clients only (all distribution channels). No UK PRIIPs key information document (KID) has been prepared as not available to retail in UK.

MiFID II professionals/ECPs-only / No EU PRIIPs KID - Manufacturer target market (MiFID II product governance) is eligible counterparties and professional clients only (all distribution channels). No EU PRIIPs key information document (KID) has been prepared as not available to retail in EEA.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFTBRGDBBUBDGDD
Date   Source Headline
23rd Mar 20202:00 pmRNSDirector/PDMR Shareholding
20th Mar 20204:38 pmRNSPrice Monitoring Extension
20th Mar 202010:20 amRNSSecond Price Monitoring Extn
20th Mar 202010:15 amRNSPrice Monitoring Extension
19th Mar 20201:36 pmRNSNotice of AGM
17th Mar 20204:42 pmRNSSecond Price Monitoring Extn
17th Mar 20204:38 pmRNSPrice Monitoring Extension
17th Mar 20202:00 pmRNSDirector/PDMR Shareholding
17th Mar 20208:10 amRNSPublication of Final Terms
16th Mar 202011:21 amRNSDirector Declaration
16th Mar 20209:30 amRNSDirector Declaration
12th Mar 20202:00 pmRNSDirector/PDMR Shareholding
11th Mar 202011:29 amRNSSubordinated Debt Exchange Offer Results
10th Mar 20202:00 pmRNSDirector/PDMR Shareholding
2nd Mar 20203:19 pmRNSSubordinated Debt Exchange Offer
28th Feb 20202:27 pmRNSTotal Voting Rights
26th Feb 202012:47 pmRNSDirector Declaration
26th Feb 202010:36 amRNS2019 Annual Report on Form 20-F
25th Feb 20207:00 amRNSBlock Listing of Shares
20th Feb 202012:59 pmRNSPublication of Supplementary Prospectus
20th Feb 20207:00 amRNS2019 Full Year Results
20th Feb 20207:00 amRNS2019 Annual Report and Accounts
20th Feb 20207:00 amRNS2019 Full Year Results
20th Feb 20207:00 amRNS2019 Annual Report and Accounts
12th Feb 20202:00 pmRNSDirector/PDMR Shareholding
31st Jan 20202:00 pmRNSTotal Voting Rights
15th Jan 20205:06 pmRNSPublication of Final Terms dated 13 January 2020
13th Jan 20202:00 pmRNSDirector/PDMR Shareholding
2nd Jan 20202:37 pmRNSBlock listing Interim Review
31st Dec 201911:00 amRNSTotal Voting Rights
30th Dec 20192:00 pmRNSDirector/PDMR Shareholding
18th Dec 20192:00 pmRNSDirector/PDMR Shareholding
18th Dec 20192:00 pmRNSAdditional Listing
16th Dec 20195:52 pmRNSBank of England Stress Test Passed
12th Dec 20192:00 pmRNSDirector/PDMR Shareholding
29th Nov 20192:00 pmRNSTotal Voting Rights
25th Nov 20197:00 amRNSDirector Declaration
13th Nov 20192:00 pmRNSDirector/PDMR Shareholding
12th Nov 20193:48 pmRNSPublication of Final Terms dated 8 November 2019
1st Nov 20192:05 pmRNSPublication of Supplement Prospectus
31st Oct 20192:00 pmRNSTotal Voting Rights
31st Oct 20197:00 amRNSJuan Colombas to Retire During Q3 2020
31st Oct 20197:00 amRNSNon Executive Board Changes
31st Oct 20197:00 amRNSQ3 2019 Interim Management Statement
11th Oct 20191:00 pmRNSDirector/PDMR Shareholding
8th Oct 20193:09 pmRNSDirector/PDMR Shareholding
30th Sep 20192:00 pmRNSDirector/PDMR Shareholding
30th Sep 20192:00 pmRNSTotal Voting Rights
18th Sep 20192:00 pmRNSDirector/PDMR Shareholding
13th Sep 20192:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.